Biopharmaceutical studies on drug/conjugated-metabolite interactions. I. Fate of acetaminophen sulfate, a major conjugated metabolite of acetaminophen, in rats

Taiji Nakayama, Taiji Sawamoto, Yuji Kurosaki, Toshikiro Kimura

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The plasma elimination kinetics and intestinal absorption kinetics of acetaminophen sulfate (APAPS), a major conjugated metabolite of acetaminophen (APAP), indispensable for the kinetic elucidation of drug/APAPS interactions, were examined in rats. Plasma elimination kinetics of APAPS after i.v. administration could be described by a two-compartment model with linear parameters to the dose. The deconjugation of intravenously administered APAPS, i.e., the formation of APAP, was recognized in neither plasma, urine nor bile. Approx. 80% of intravenously administered APAPS was excreted as the unchanged form in the urine in 4 h while biliary excretion was only a few percent of the dose. Plasma profiles of APAPS after oral administration showed two peaks, but the second one disappeared when the rat was pretreated with kanamycin sulfate. However, APAPS permeation through the small- and the large-intestinal walls determined in situ was not altered after kanamycin treatment. High APAPS-hydrolyzing activities present in the cecal and colonic contents and the feces, but not in the small-intestinal contents, completely disappeared after kanamycin treatment. Thus, part of the orally administered APAPS was absorbed as the unchanged form from both the small and large intestines, and considerable amounts of the remainder were absorbed from the large intestine as APAP after enzymatic hydrolysis by the intestinal microflora during transit through the lower bowel.

Original languageEnglish
Pages (from-to)55-63
Number of pages9
JournalInternational Journal of Pharmaceutics
Volume121
Issue number1
DOIs
Publication statusPublished - Jul 6 1995

Fingerprint

Acetaminophen
Pharmaceutical Preparations
Kanamycin
Large Intestine
acetaminophen sulfate ester
Urine
Gastrointestinal Contents
Intestinal Absorption
Feces
Bile
Small Intestine
Oral Administration
Linear Models
Hydrolysis
Pharmacokinetics

Keywords

  • Acetaminophen
  • Acetaminophen sulfate
  • Conjugated metabolite
  • Intestinal microflora
  • Kanamycin sulfate
  • Pharmacokinetics
  • Rat

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Biopharmaceutical studies on drug/conjugated-metabolite interactions. I. Fate of acetaminophen sulfate, a major conjugated metabolite of acetaminophen, in rats. / Nakayama, Taiji; Sawamoto, Taiji; Kurosaki, Yuji; Kimura, Toshikiro.

In: International Journal of Pharmaceutics, Vol. 121, No. 1, 06.07.1995, p. 55-63.

Research output: Contribution to journalArticle

@article{f1e6c353a5fa43078ee9c29cc734a843,
title = "Biopharmaceutical studies on drug/conjugated-metabolite interactions. I. Fate of acetaminophen sulfate, a major conjugated metabolite of acetaminophen, in rats",
abstract = "The plasma elimination kinetics and intestinal absorption kinetics of acetaminophen sulfate (APAPS), a major conjugated metabolite of acetaminophen (APAP), indispensable for the kinetic elucidation of drug/APAPS interactions, were examined in rats. Plasma elimination kinetics of APAPS after i.v. administration could be described by a two-compartment model with linear parameters to the dose. The deconjugation of intravenously administered APAPS, i.e., the formation of APAP, was recognized in neither plasma, urine nor bile. Approx. 80{\%} of intravenously administered APAPS was excreted as the unchanged form in the urine in 4 h while biliary excretion was only a few percent of the dose. Plasma profiles of APAPS after oral administration showed two peaks, but the second one disappeared when the rat was pretreated with kanamycin sulfate. However, APAPS permeation through the small- and the large-intestinal walls determined in situ was not altered after kanamycin treatment. High APAPS-hydrolyzing activities present in the cecal and colonic contents and the feces, but not in the small-intestinal contents, completely disappeared after kanamycin treatment. Thus, part of the orally administered APAPS was absorbed as the unchanged form from both the small and large intestines, and considerable amounts of the remainder were absorbed from the large intestine as APAP after enzymatic hydrolysis by the intestinal microflora during transit through the lower bowel.",
keywords = "Acetaminophen, Acetaminophen sulfate, Conjugated metabolite, Intestinal microflora, Kanamycin sulfate, Pharmacokinetics, Rat",
author = "Taiji Nakayama and Taiji Sawamoto and Yuji Kurosaki and Toshikiro Kimura",
year = "1995",
month = "7",
day = "6",
doi = "10.1016/0378-5173(95)00003-2",
language = "English",
volume = "121",
pages = "55--63",
journal = "International Journal of Pharmaceutics",
issn = "0378-5173",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Biopharmaceutical studies on drug/conjugated-metabolite interactions. I. Fate of acetaminophen sulfate, a major conjugated metabolite of acetaminophen, in rats

AU - Nakayama, Taiji

AU - Sawamoto, Taiji

AU - Kurosaki, Yuji

AU - Kimura, Toshikiro

PY - 1995/7/6

Y1 - 1995/7/6

N2 - The plasma elimination kinetics and intestinal absorption kinetics of acetaminophen sulfate (APAPS), a major conjugated metabolite of acetaminophen (APAP), indispensable for the kinetic elucidation of drug/APAPS interactions, were examined in rats. Plasma elimination kinetics of APAPS after i.v. administration could be described by a two-compartment model with linear parameters to the dose. The deconjugation of intravenously administered APAPS, i.e., the formation of APAP, was recognized in neither plasma, urine nor bile. Approx. 80% of intravenously administered APAPS was excreted as the unchanged form in the urine in 4 h while biliary excretion was only a few percent of the dose. Plasma profiles of APAPS after oral administration showed two peaks, but the second one disappeared when the rat was pretreated with kanamycin sulfate. However, APAPS permeation through the small- and the large-intestinal walls determined in situ was not altered after kanamycin treatment. High APAPS-hydrolyzing activities present in the cecal and colonic contents and the feces, but not in the small-intestinal contents, completely disappeared after kanamycin treatment. Thus, part of the orally administered APAPS was absorbed as the unchanged form from both the small and large intestines, and considerable amounts of the remainder were absorbed from the large intestine as APAP after enzymatic hydrolysis by the intestinal microflora during transit through the lower bowel.

AB - The plasma elimination kinetics and intestinal absorption kinetics of acetaminophen sulfate (APAPS), a major conjugated metabolite of acetaminophen (APAP), indispensable for the kinetic elucidation of drug/APAPS interactions, were examined in rats. Plasma elimination kinetics of APAPS after i.v. administration could be described by a two-compartment model with linear parameters to the dose. The deconjugation of intravenously administered APAPS, i.e., the formation of APAP, was recognized in neither plasma, urine nor bile. Approx. 80% of intravenously administered APAPS was excreted as the unchanged form in the urine in 4 h while biliary excretion was only a few percent of the dose. Plasma profiles of APAPS after oral administration showed two peaks, but the second one disappeared when the rat was pretreated with kanamycin sulfate. However, APAPS permeation through the small- and the large-intestinal walls determined in situ was not altered after kanamycin treatment. High APAPS-hydrolyzing activities present in the cecal and colonic contents and the feces, but not in the small-intestinal contents, completely disappeared after kanamycin treatment. Thus, part of the orally administered APAPS was absorbed as the unchanged form from both the small and large intestines, and considerable amounts of the remainder were absorbed from the large intestine as APAP after enzymatic hydrolysis by the intestinal microflora during transit through the lower bowel.

KW - Acetaminophen

KW - Acetaminophen sulfate

KW - Conjugated metabolite

KW - Intestinal microflora

KW - Kanamycin sulfate

KW - Pharmacokinetics

KW - Rat

UR - http://www.scopus.com/inward/record.url?scp=0028998699&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028998699&partnerID=8YFLogxK

U2 - 10.1016/0378-5173(95)00003-2

DO - 10.1016/0378-5173(95)00003-2

M3 - Article

VL - 121

SP - 55

EP - 63

JO - International Journal of Pharmaceutics

JF - International Journal of Pharmaceutics

SN - 0378-5173

IS - 1

ER -